Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group. [electronic resource]
Producer: 19990428Description: 293-302 p. digitalISSN:- 0263-6352
- Administration, Oral
- Aged
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors -- administration & dosage
- Benzimidazoles -- administration & dosage
- Benzoates -- administration & dosage
- Blood Pressure -- drug effects
- Blood Pressure Monitoring, Ambulatory
- Diuretics
- Dose-Response Relationship, Drug
- Double-Blind Method
- Enalapril -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Hydrochlorothiazide -- administration & dosage
- Hypertension -- blood
- Male
- Quality of Life
- Receptor, Angiotensin, Type 1
- Receptor, Angiotensin, Type 2
- Renin -- blood
- Safety
- Sodium Chloride Symporter Inhibitors -- administration & dosage
- Supine Position
- Telmisartan
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.